Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet (British edition), 2014-03, Vol.383 (9921), p.955-962 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 15, 2014 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62343-0 ;PMID: 24315724 ;CODEN: LANCAOFull text available |
|
2 |
Material Type: Article
|
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes MellitusCirculation (New York, N.Y.), 2019-05, Vol.139 (22), p.2528-2536 [Peer Reviewed Journal]2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.040130 ;PMID: 30882238Full text available |
|
3 |
Material Type: Article
|
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trialThe Lancet (British edition), 2015-06, Vol.385 (9984), p.2288-2295 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 6, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61943-7 ;PMID: 25769361 ;CODEN: LANCAOFull text available |
|
4 |
Material Type: Article
|
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 TrialJournal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1372-1382 [Peer Reviewed Journal]The Authors ;2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 21, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.12.031 ;PMID: 28302288Full text available |
|
5 |
Material Type: Article
|
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 TrialJournal of the American Heart Association, 2016-05, Vol.5 (5), p.n/a [Peer Reviewed Journal]2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.116.003432 ;PMID: 27207971Full text available |
|
6 |
Material Type: Article
|
The importance of dosing frequency on the safety of DOACsAmerican heart journal plus, 2022-11, Vol.23, p.100216-100216, Article 100216 [Peer Reviewed Journal]2022 The Author ;2022 The Author. ;ISSN: 2666-6022 ;EISSN: 2666-6022 ;DOI: 10.1016/j.ahjo.2022.100216 ;PMID: 38560657Full text available |
|
7 |
Material Type: Article
|
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48European heart journal, 2014-06, Vol.35 (22), p.1457-1465 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2013. For permissions please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2013. For permissions please email: journals.permissions@oup.com. 2013 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/eht500 ;PMID: 24302269Full text available |
|
8 |
Material Type: Article
|
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous ThromboembolismCirculation (New York, N.Y.), 2020-05, Vol.141 (20), p.1600-1607 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.046397 ;PMID: 32223429Full text available |
|
9 |
Material Type: Article
|
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)The American heart journal, 2010-10, Vol.160 (4), p.635-641.e2 [Peer Reviewed Journal]Mosby, Inc. ;2010 Mosby, Inc. ;2015 INIST-CNRS ;Copyright © 2010 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Oct 2010 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2010.06.042 ;PMID: 20934556 ;CODEN: AHJOA2Full text available |
|
10 |
Material Type: Article
|
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trialThe Lancet (British edition), 2015-06, Vol.385 (9984), p.2280-2287 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 6, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61994-2 ;PMID: 25769357 ;CODEN: LANCAOFull text available |
|
11 |
Material Type: Article
|
Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillationPloS one, 2021-03, Vol.16 (3), p.e0248134-e0248134 [Peer Reviewed Journal]COPYRIGHT 2021 Public Library of Science ;COPYRIGHT 2021 Public Library of Science ;2021 Ravvaz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Ravvaz et al 2021 Ravvaz et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0248134 ;PMID: 33735259Full text available |
|
12 |
Material Type: Article
|
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation – An ENGAGE AF-TIMI 48 SubanalysisCirculation Journal, 2016/03/25, Vol.80(4), pp.860-869 [Peer Reviewed Journal]2016 THE JAPANESE CIRCULATION SOCIETY ;ISSN: 1346-9843 ;EISSN: 1347-4820 ;DOI: 10.1253/circj.CJ-15-1082 ;PMID: 26888149Full text available |
|
13 |
Material Type: Article
|
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 TrialJournal of the American Heart Association, 2018-08, Vol.7 (16), p.e008987 [Peer Reviewed Journal]2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.118.008987 ;PMID: 30369307Full text available |
|
14 |
Material Type: Article
|
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trialEuropean heart journal, 2017-03, Vol.38 (12), p.888 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehw565 ;PMID: 28064150Full text available |
|
15 |
Material Type: Article
|
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 TrialJournal of the American Heart Association, 2016-02, Vol.5 (2), p.n/a [Peer Reviewed Journal]2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.115.002587 ;PMID: 26908401Full text available |
|
16 |
Material Type: Article
|
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumabPloS one, 2022-04, Vol.17 (4), p.e0266615-e0266615 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Korthauer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;2022 Korthauer et al 2022 Korthauer et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0266615 ;PMID: 35404972Full text available |
|
17 |
Material Type: Article
|
Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal ImpairmentClinical and applied thrombosis/hemostasis, 2021, Vol.27, p.1076029620987900 [Peer Reviewed Journal]The Author(s) 2021 ;The Author(s) 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 2021 SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 1076-0296 ;EISSN: 1938-2723 ;DOI: 10.1177/1076029620987900 ;PMID: 33517715Full text available |
|
18 |
Material Type: Article
|
The Challenge of Getting it Just RightJournal of the American College of Cardiology, 2015-08, Vol.66 (7), p.788-790 [Peer Reviewed Journal]American College of Cardiology Foundation ;Copyright Elsevier Limited Aug 18, 2015 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.06.1082Full text available |
|
19 |
Material Type: Article
|
Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin – Insights From the ENGAGE AF-TIMI 48 TrialCirculation Journal, 2015/11/25, Vol.79(12), pp.2560-2567 [Peer Reviewed Journal]2015 THE JAPANESE CIRCULATION SOCIETY ;ISSN: 1346-9843 ;EISSN: 1347-4820 ;DOI: 10.1253/circj.CJ-15-0574 ;PMID: 26460886Full text available |
|
20 |
Material Type: Article
|
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 TrialJournal of the American Heart Association, 2016-07, Vol.5 (7), p.n/a [Peer Reviewed Journal]2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.116.003735 ;PMID: 27402235Full text available |